A randomized controlled trial conducted in Europe found that dequalinium chloride has good efficacy for treating bacterial vaginosis (BV) in women without the use of antibiotics. When compared with the antibiotic metronidazole, dequalinium chloride was not only noninferior, it also had better tolerability and fewer adverse events, as published in JAMA Network Open. Study authors believe dequalinium chloride could help reduce antibiotic consumption and could be considered as first-line treatment for bacterial vaginosis with less …
Read More